A vaccine against SARS coronavirus would be highly significant in preventing future outbreaks of this emerging disease. Genetic vaccines (DNA and adenoviral) expressing various proteins, including spike glycoprotein, envelope, and nucleoprotein. These were tested to determine immune response. Mechanisms of infection and immune correlates of protection were also studied.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI005056-01
Application #
6822657
Study Section
(VRC)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code